HRMY
Harmony Biosciences Holdings Inc

17,049
Mkt Cap
$1.65B
Volume
710,574.00
52W High
$40.87
52W Low
$25.52
PE Ratio
10.54
HRMY Fundamentals
Price
$28.54
Prev Close
$29.05
Open
$28.54
50D MA
$36.10
Beta
0.84
Avg. Volume
647,465.60
EPS (Annual)
$2.71
P/B
1.89
Rev/Employee
$2.96M
$1,650.46
Loading...
Loading...

About

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the provision of development and commercialization of therapies for the treatment of neurological disorders. Its product, WAKIX, is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded by Jeffrey S. Aronin on July 25, 2017 and is headquartered in Plymouth Meeting, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
293

Frequently Asked Questions

What is Market Cap of Harmony Biosciences Holdings Inc?
What is the 52-week high for Harmony Biosciences Holdings Inc?
What is the 52-week low for Harmony Biosciences Holdings Inc?
What is Harmony Biosciences Holdings Inc stock price today?
What was Harmony Biosciences Holdings Inc stock price yesterday?
What is the PE ratio of Harmony Biosciences Holdings Inc?
What is the Price-to-Book ratio of Harmony Biosciences Holdings Inc?
What is the 50-day moving average of Harmony Biosciences Holdings Inc?
How many employees does Harmony Biosciences Holdings Inc have?

Latest HRMY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.